What is The Oncology Institute, Inc.'s debt maturity - 2024?

The Oncology Institute, Inc. (TOI) reported debt maturity - 2024 of $0 in Q1 2026.

The Oncology Institute, Inc. TOI Debt Maturity - 2024

Debt Maturity - 2024 at other companies

Option Care Health, Inc.OPCH

——

Jazz PharmaceuticalsJAZZ

——

Other financials

Income statement

See full

Revenue$147.4M+41.2%

Operating income-$6.5M+34.3%

Net income-$2.5M+87.3%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$30.3M-23.8%

Total debt$104.9M+2.5%

Total equity-$16.3M-421%

Total assets$168.2M+2.6%

Cash flow

See full

Operating cash flow-$2.2M+55.6%

CapEx$1.0M+218%

Free cash flow-$3.3M+38.7%

Valuation

See full

Market cap$511.91M+133%

Enterprise value$586.58M+108%

P/S0.9×+0.4×

Profitability

See full

Operating margin-6%-2.1pp

Net margin-8%-2.7pp

FCF margin-5.1%—

Returns & leverage

See full

Return on equity-277.6%-700pp

Debt / equity20.2×+17.3×

Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s debt maturity - 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Oncology Institute, Inc.'s debt maturity - 2024?: The Oncology Institute, Inc. (TOI) reported debt maturity - 2024 of $0 in Q1 2026.